Innovation Pharmaceuticals Inc (IPIX)

[Lemoncat]

I think you might have responded to the wrong person. Not sure where the R/S talk came from.

I don't think we're doing a R/S or a significant share sale agreement.

The hope is we will land a subsistence B-OM deal that will allow us to advance B-UC and Kevetrin through oral phase 2 trials. That will allow lucrative partnerships without decimating the current share structure.

Funding B-OM Phase 3, B-UC Phase 1 and 2, and Kevetrin Phase 2 oral will likely balloon our share count toward 700M-900M. It will cost current shareholders tremendous equity percentages of ALL drugs in the pipeline BEFORE we partner them for 20% royalties.

It's clear we need either B-UC or Kevetrin to succeed in a phase 2 oral trial if we ever hope to get back to CTIX valuations. Holding out hope they can secure a B-OM deal that facilitates this.

Go IPIX!